Navigation Links
Loma Linda University Expands Vision Screening Program With Revolutionary New Screening Device, Spot
Date:9/29/2011

LAKE MARY, Fla., Sept. 29, 2011 /PRNewswire/ -- PediaVision today announced that Loma Linda University's Vision Intervention Program is the first in the State of California to receive the revolutionary new vision screener from PediaVision called "Spot."  The University's Department of Ophthalmology is offering free vision screenings to children from Riverside County, thanks to the support of First 5 Riverside, which invests in partnerships committed to improving physical health, social-emotional health, cognitive development, a stable home environment and schools.

Loma Linda University is planning on screening thousands of children to provide them with early intervention in order to foster proper visual development.  Spot will allow them to accomplish that goal by quickly and effectively screening children for indications of vision issues.  The screening results identify those in need of a complete vision exam from an eye care specialist.

On the Spot

Spot is a new breakthrough vision screening device that has an incredibly quick capture time of less than one second.  This unique capability makes it possible to screen numerous preschool age children from Riverside County during one school day, which dramatically lowers the cost to screen students.  The Wi-Fi enabled handheld device makes vision screening as easy as taking a photo and can be easily used by anyone when screening children from 6 months through adults.

Spot's touch screen interface clearly displays the results accurately and instantly.  Access to the screening data is immediate and Spot facilitates a large scale data analysis.  Thousands of children can be screened, and educators can instantly print reports, monitor follow-up care and show supporters the statistics behind childhood vision issues.

"Our goal is to give every child the opportunity to reach their full potential," said David Melnik, president and chief executive officer of PediaVision.  "Spot demonstrates how innovation can drive profound changes in communities around the country.  For the first time consistent and comprehensive vision screening is feasible on a global basis."

Vision Disability, Number One Health Issue

Nationwide, there is an on-going and urgent need for Spot.  The U. S. Centers for Disease Control and Prevention (CDC) state that vision disability is the single most prevalent disabling condition among children.  Approximately 80 percent(1) of what children learn in their early school years is visual, so if they can't see a teacher's writing on the blackboard, they will struggle.

The current standard for vision screening is primarily based on subjective analysis from a chart invented 149 years ago.  In parallel, vision problems rise as children get older.  For children 6 to 11 years old, an estimated 21.5 percent have a vision problem.  Older students 12-17 years old are estimated at 24 percent.(2)

In a recent study of the top seven health issues in schools, vision disability is priority number one.(3)  This clearly shows evidence that addressing the prevalence of visions disorders can improve student outcomes.  Statistics show an incredible need, the CDC states that less than 15 percent of all preschool children receive an eye exam and fewer than 22 percent receive any type of vision screening.

Today, of all school-age children across America, 25 percent suffer from a vision problem,(2) yet in the 9 to 15 year age group, only 10% of those needing glasses actually had them.

New Vision Screening Standard

PediaVision is committed to setting a new vision screening standard with Spot.  The technology was developed to detect vision disorders quickly, conveniently and affordably as possible.

In as long as it takes to snap a finger, Spot can identify the most common vision issues that affect learning in school-age children.  A quick screening is able to detect nearsightedness (myopia), blurred vision (astigmatism), farsightedness (hyperopia) and amblyopic conditions.  Amblyopia is the loss or lack of development of central vision in one eye that is unrelated to any eye health problem and is not correctable with lenses.  Amblyopia affects 1 in 50 children and must be identified at an early age in order to correct a child's vision.

The American Academy of Ophthalmology recommends that during childhood, babies up to age 2 should have vision screenings during regular pediatric visits, and screenings every one or two years from ages 3 to 19.  Spot is equally effective for pre-verbal, pre-school and school age children, including young adults.

To Order Spot Vision

Interested parties should contact PediaVision's Vice President, Jeff Mortensen (Jmortensen@pediavision.com), to learn how to acquire Spot vision.

About PediaVision

PediaVision, inventor of the Spot vision screener, is dedicated to solving the critical problem of undiagnosed vision disorders and transforming the lives of thousands of children each day.  Automated and objective vision screening empowers organizations in public health and private medicine to positively affect the outcomes of a child's education performance.

Supported by ophthalmologists, optometrists, scientists and leading technology innovators, the Spot vision screener is breakthrough technology and represents what vision screening should be.  Please visit www.pediavision.com.

(1) American Optometric Association
(2) Center for Health and Health Care in Schools. Childhood Vision: What the research tells us. 2004.
(3) Basch, C.E. (2010) Healthier Students Are Better Learners: A Missing Link in Efforts to Close the Achievement Gap.


'/>"/>
SOURCE PediaVision
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
2. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
3. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
4. CureHIV Reaches Out to Bill and Melinda Gates to Fund LiSAVIOR
5. Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac(TM) Development at Prestigious International Symposium
6. Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea
7. Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results
8. Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
9. Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines
10. Ionian Technologies, Inc. Receives Additional Funding from the Bill & Melinda Gates Foundation to Develop Point-of-Care Diagnostic Tests for the Developing World
11. AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... ORLANDO, Fla. , Feb. 20, 2017   ... will migrate its Amadeus precision medicine platform ... Health,s software currently manages over 110 million patient records ... approach to developing cloud-based, big data solutions built on ... Director of Healthcare and Life Sciences. "The AWS Cloud ...
(Date:2/20/2017)... Research and Markets has announced the addition of the ... report to their offering. ... An increasing number of patients suffering ... tension free repair procedures and increasing demand for minimally invasive ... market. However, Inconsistent reimbursement and the high cost of hernia ...
(Date:2/20/2017)... 20, 2017 According to a new market research ... powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End ... The market is projected to reach USD 52.37 Billion by 2021 from ... forecast period. Continue Reading ... ...
Breaking Medicine Technology:
(Date:2/20/2017)... , ... February 20, 2017 , ... ... check-in, a cloud-based self-service technology that runs on the Posiflex XT-series of touch ... 1076 during HIMSS17 in Orlando, Florida. The terminal provider Posiflex is ...
(Date:2/20/2017)... Sunapee, NH (PRWEB) , ... February 20, 2017 , ... ReportingMD, a Population Health Software ... rapid growth of the company. The new location will triple the size of the ... location for the town of Sunapee, NH. , “We are excited to expand ...
(Date:2/20/2017)... Tampa, FL (PRWEB) , ... February 20, 2017 ... ... $20,000 gift from Constellation Brands to purchase a new ultrasound-enhanced thrombolysis machine, a ... ultrasonic waves. The gift was facilitated by the Pepin Family Foundation. , “We ...
(Date:2/19/2017)... ... 2017 , ... Orbita, Inc., a leading provider ... Healthwise ® at HIMSS 2017 to showcase a breakthrough in remote ... technology and services, will demonstrate a voice-powered knowedge assistant based on Orbita ...
(Date:2/18/2017)... ... , ... Park Cities Pet Sitter President, Joette White, has been featured on ... The episode, which was posted this week, features a 30-minute interview of White ... Cities Pet Sitter’s being awarded the 2017 National Association of Professional Pet Sitter’s Business ...
Breaking Medicine News(10 mins):